CJC 1295 & Ipamorelin Blend (No DAC) X 10mg
Sold by FMI Health
INR 11,953.00
View at FMI Health- Store
- fmihealth.com
- Brand
- Biolongevity Labs
- Product type
- Peptides
- Collected
- 2026-11-20
From the retailer
Description--CJC-1295 & Ipamorelin Blend - Growth Hormone Secretagogue Research Complex (10 mg, No DAC)
This peptide blend combines CJC-1295 (No DAC) and Ipamorelin, two complementary growth hormone secretagogues that act on distinct receptor pathways to amplify GH release.
Mechanistic Claims
- CJC-1295 (No DAC, 5 mg)
- Synthetic GHRH analog retaining 29 amino acids of native GHRH with four substitutions for stability and receptor affinity.
- Stimulates pituitary GHRH receptors to increase pulsatile GH secretion.
- Elevates circulating IGF-1 levels, supporting anabolic and regenerative pathways.
- Mimics natural GH release patterns without prolonged receptor binding.
- Ipamorelin (5 mg)
-
- Synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH₂).
- Selective ghrelin receptor agonist that triggers GH release from the pituitary.
- High potency with minimal off-target hormonal effects (does not significantly affect cortisol, prolactin, or ACTH).
- Provides a clean GH stimulation profile compared to other GHS compounds.
Synergistic Potential
- Dual receptor targeting (GHRH + ghrelin) amplifies GH release.
- Promotes IGF-1 elevation while maintaining physiological GH pulsatility.
- Offers a balanced approach to studying growth hormone dynamics without excessive endocrine disruption.
Research Applications
- Growth hormone secretion and regulation studies
- IGF-1 mediated anabolic and regenerative pathways
- Comparative analysis of GHRH vs. ghrelin receptor agonism
- Endocrine signaling and pituitary function models
CJC 1295 Ipamorelin Research
CJC-1295 and ipamorelin have both been researched for their potential to stimulate growth hormone production.
Growth Hormone Release
In GHRH knockout mice, CJC-1295 administration normalized body weight and length, demonstrating its potential in treating growth deficiencies. Daily administration was more effective than less frequent
- Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J., Frohman, L., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.. American journal of physiology. Endocrinology and metabolism, 291 6, E1290-4 . .
- Teichman, S., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J., & Frohman, L. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.. The Journal of clinical endocrinology and metabolism, 91 3, 799-805 . .
- Raun, K., Hansen, B., Johansen, N., Thøgersen, H., Madsen, K., Ankersen, M., & Andersen, P. (1998). Ipamorelin, the first selective growth hormone secretagogue.. European journal of endocrinology, 139 5, 552-61 . .
- Johansen, P., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T., Wilken, M., & Orskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 9 2, 106-13 . .
- Gobburu, J., Agersø, H., Jusko, W., & Ynddal, L. (1999). Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers. Pharmaceutical Research, 16, 1412-1416. .
Label-- Peptide Information
|
Property |
Value |
|---|---|
|
Peptide Name |
CJC 1295 |
|
Peptide Sequence |
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala- Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys |
|
Molecular Formula |
C165H269N47O46 |
|
Molecular Weight |
|
|
CAS Number |
446262-90-4 |
|
PubChem CID |
|
|
Synonyms |
CJC 1295, CJC-1295, 62RC32V9N7, DTXSID501027567 |
| Property | Value |
|---|---|
| Peptide Name | Ipamorelin |
| Peptide Sequence | Aib-His-D-2Nal-D-Phe-Lys |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.9 g/mol |
| CAS Number | 170851-70-4 |
| PubChem CID | 9831659 |
| Synonyms | 170851-70-4, Ipamorelin [INN], NNC-26-0161, UNII-Y9M3S784Z6 |
Dosage-- This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.